Grant EC - Search Results

1

Hormone replacement therapy and risk of breast cancer.

Grant EC. Grant EC. JAMA. 2002 May 8;287(18):2360; author reply 2361. JAMA. 2002. PMID: 11988049 No abstract available.

2

Estrogen plus progestin and colorectal cancer in postmenopausal women.

Grant EC. Grant EC. N Engl J Med. 2004 Jun 3;350(23):2417-9; author reply 2417-9. doi: 10.1056/NEJM200406033502319. N Engl J Med. 2004. PMID: 15175448 No abstract available.

3

Oral contraceptives and the risk of breast cancer.

Grant EC. Grant EC. N Engl J Med. 2002 Oct 31;347(18):1448-9; author reply 1448-9. N Engl J Med. 2002. PMID: 12418035 No abstract available.

4

Estrogen-receptor polymorphism and hormone-replacement therapy.

Grant EC. Grant EC. N Engl J Med. 2002 Sep 5;347(10):762-3; author reply 762-3. N Engl J Med. 2002. PMID: 12214623 No abstract available.

5

Reduction in mortality from breast cancer: fall in use of hormones could have reduced breast cancer mortality.

Grant EC. Grant EC. BMJ. 2005 Apr 30;330(7498):1024; author reply 1025. doi: 10.1136/bmj.330.7498.1024-a. BMJ. 2005. PMID: 15860833 Free PMC article. No abstract available.

6

Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.

Grant EC. Grant EC. J Natl Cancer Inst. 2011 Jul 6;103(13):1069; reply 1069-70. doi: 10.1093/jnci/djr191. Epub 2011 Jun 23. J Natl Cancer Inst. 2011. PMID: 21700925 No abstract available.

7

Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy.

Grant ECG. Grant ECG. Am J Obstet Gynecol. 2017 Aug;217(2):232-233. doi: 10.1016/j.ajog.2017.05.005. Epub 2017 May 11. Am J Obstet Gynecol. 2017. PMID: 28502754 No abstract available.

8

Oral contraceptives and risk of breast cancer.

Grant EC. Grant EC. Lancet. 1994 Nov 12;344(8933):1364. Lancet. 1994. PMID: 7968046 No abstract available.

9

Breast cancer and hormone exposure.

Grant EC, Antony HM, Myhill S, Price EH, Steel CM. Grant EC, et al. Lancet. 1996 Sep 7;348(9028):682; author reply 683. doi: 10.1016/S0140-6736(05)65103-3. Lancet. 1996. PMID: 8782768 No abstract available.

10

Risks of hormone replacement therapy.

Grant EC, Price EH, Steel CM. Grant EC, et al. Lancet. 1999 Oct 9;354(9186):1302-3. doi: 10.1016/s0140-6736(05)76078-5. Lancet. 1999. PMID: 10520664 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results